| General Information |
| Business: |
(Incorporated in the Cayman Islands)
We are a newly established blank check company. We intend to focus on the healthcare or healthcare-related industries. In particular, we are targeting companies in the drug development and commercialization, diagnostic and healthcare technology, and service sectors, where our management has extensive investment experience.
(Note: Research Alliance Corp. IV priced its SPAC IPO in sync with the terms in the prospectus: 7.5 million shares at $10.00 each to raise $75 million. Unlike most SPACs, Research Alliance Corp. IV’s SPAC was a stock-only deal. It did not include warrants or rights.)
|
| Industry: |
BLANK CHECKS |
| Employees: |
0 |
| Founded: |
2026 |
| Contact Information |
| Address |
600 Fifth Avenue, 23rd Floor, New York, NY 10020 |
| Phone Number |
(617) 778 2500 |
| Web Address |
|
| View Prospectus: |
Research Alliance Corp. IV (Stock-Only) |
| Financial Information |
| Market Cap |
$90.99mil |
| Revenues |
$0.0 mil (last 12 months) |
| Net Income |
$0.0 mil (last 12 months) |
| IPO Profile |
| Symbol |
RACD |
| Exchange |
NASDAQ |
| Shares (millions): |
7.5 |
| Price range |
$10.00 - $10.00 |
| Est. $ Volume |
$75.0 mil |
| Manager / Joint Managers |
Leerink Partners |
| CO-Managers |
|
| Expected To Trade: |
7/13/2026 |
|
Status:
|
Priced |
| Quiet Period Expiration Date: |
Available only to Subscribers |
| Lock-Up Period Expiration Date: |
Available only to Subscribers |
| SCOOP Rating |
Available only to Subscribers |
| Rating Change |
Available only to Subscribers |
